The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model

The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model

Bibliographic Details
Main Authors:	Hélène Le Ribeuz, David Montani, Fabrice Antigny
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Physiology
Subjects:	TASK-1 KCNK3 pulmonary hypertension atrial fibrillation A293
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2021.668267/full

Similar Items

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
by: Hélène Le Ribeuz, et al.
Published: (2020-09-01)

The Experimental TASK-1 Potassium Channel Inhibitor A293 Can Be Employed for Rhythm Control of Persistent Atrial Fibrillation in a Translational Large Animal Model
by: Felix Wiedmann, et al.
Published: (2021-01-01)

In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression
by: Hélène Le Ribeuz, et al.
Published: (2020-07-01)

Pulmonary hypertension associated with diazoxide: the SUR1 paradox
by: David Montani, et al.
Published: (2023-11-01)

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
by: Joana Santos-Gomes, et al.
Published: (2022-03-01)

Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension
by: Hélène Le Ribeuz, et al.
Published: (2023-01-01)

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
by: Manuel Kraft, et al.
Published: (2021-03-01)

Role of Store-Operated Ca<sup>2+</sup> Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
by: Bastien Masson, et al.
Published: (2021-11-01)

MicroRNAs Regulate TASK‐1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation
by: Felix Wiedmann, et al.
Published: (2022-04-01)

Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells
by: Hélène Le Ribeuz, et al.
Published: (2020-10-01)

Role of Ion Channels in the Development of Pulmonary Arterial Hypertension
by: Fabrice Antigny
Published: (2022-09-01)

Pharmacologic TWIK‐Related Acid‐Sensitive K+ Channel (TASK‐1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model
by: Felix Wiedmann, et al.
Published: (2020-05-01)

Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters
by: Benoît Chevalier, et al.
Published: (2022-08-01)

The SOCE Machinery: An Unbalanced Knowledge between Left and Right Ventricular Pathophysiology
by: Jessica Sabourin, et al.
Published: (2022-10-01)

Negative Influence by the Force: Mechanically Induced Hyperpolarization via K<sub>2P</sub> Background Potassium Channels
by: Miklós Lengyel, et al.
Published: (2021-08-01)

A potential role of mechano-gated potassium channels in meningioma-related seizures
by: Ivan Bogdanović, et al.
Published: (2023-10-01)

Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis
by: Ling-Hui Chu, et al.
Published: (2022-05-01)

KCNK5 is Functionally Down-Regulated Upon Long-Term Hypotonicity in Ehrlich Ascites Tumor Cells
by: Signe Skyum Kirkegaard, et al.
Published: (2013-11-01)

Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease
by: Spiro Khoury, et al.
Published: (2022-12-01)

Potassium Channel Protein KCNK6 Promotes Breast Cancer Cell Proliferation, Invasion, and Migration
by: Xiangchan Hou, et al.
Published: (2021-06-01)

Pré-textuais / Sumário 29.3
by: Yara Elizabeth Alves
Published: (2021-01-01)

Recurrence of atrial fibrillation and late cardiovascular events in patients with persistent atrial fibrillation after restoration of sinus rhythm
by: U.P. Chernyaha-Royko, et al.
Published: (2020-06-01)

Restoring Sinus Rhythm Improves Baroreflex Function in Patients With Persistent Atrial Fibrillation
by: Michael E. Field, et al.
Published: (2016-02-01)

Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension
by: Gabriel Redel-Traub, et al.
Published: (2022-09-01)

Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes
by: Laura Abaandou, et al.
Published: (2021-07-01)

Conduction Disorders during Sinus Rhythm in Relation to Atrial Fibrillation Persistence
by: Willemijn F. B. van der Does, et al.
Published: (2021-06-01)

A rare early-onset neonatal case of Birk-Barel syndrome presenting severe obstructive sleep apnea: a case report
by: Qian Zhang, et al.
Published: (2023-06-01)

Bupivacaine inhibits a small conductance calcium‐activated potassium type 2 channel in human embryonic kidney 293 cells
by: Hongfei Chen, et al.
Published: (2021-03-01)

Up-regulated expression of two-pore domain K+ channels, KCNK1 and KCNK2, is involved in the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary arterial hypertension
by: Natsumi Shima, et al.
Published: (2024-02-01)

The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation
by: Fausto Devecchi, et al.
Published: (2008-08-01)

HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
by: Evan Tan, et al.
Published: (2021-12-01)

Effect of Quercetin on Injury to Indomethacin-Treated Human Embryonic Kidney 293 Cells
by: Chun Chen, et al.
Published: (2021-10-01)

The Volume Activated Potassium Channel KCNK5 is Up-Regulated in Activated Human T Cells, but Volume Regulation is Impaired
by: Signe S. Kirkegaard, et al.
Published: (2016-02-01)

Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation
by: Qingsong Chen, et al.
Published: (2022-05-01)

Knocking out Ornithine Decarboxylase Antizyme 1 (OAZ1) Improves Recombinant Protein Expression in the HEK293 Cell Line
by: Laura Abaandou, et al.
Published: (2018-06-01)

Hemodynamic and Pathologic Characterization of the TASK-1−/− Mouse Does Not Demonstrate Pulmonary Hypertension
by: Melanie G. Kitagawa, et al.
Published: (2017-10-01)

CFTR and Ca2+ signaling in cystic fibrosis
by: Fabrice eAntigny, et al.
Published: (2011-10-01)

The impact of diabetes mellitus on restoring and maintaining of sinus rhythm in patients with persistent atrial fibrillation
by: Potpara Tatjana, et al.
Published: (2002-01-01)

Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line
by: Liu X, et al.
Published: (2021-02-01)

Implication from Randomized Trials of Rate and Rhythm Controls on Management of Patients with Persistent Atrial Fibrillation
by: Vincent E. Hagens, et al.
Published: (2006-04-01)